I september publicerades en vetenskaplig artikel utifrån en randomiserad kontrollerad studie om effekter av MediYoga hos patienter med paroxysmalt förmaksflimmer. Maria Wahlström (leg. ssk, med. dr) är huvudförfattare och Jörgen Medin från Röda korsets högskola är en av medförfattarna till artikeln. Studien ingår i avhandlingen Effects of MediYoga among patients with paroxysmal atrial fibrillation som Maria försvarade i januari, 2019. Nedan följer en sammanfattning av den publicerade artikeln :
Abstract
Background:
Paroxysmal atrial fibrillation is associated with impaired health-related quality of life. Yoga has been suggested to improve health-related quality of life among patients with heart failure and hypertension.
Aim:
The aim of the study was to evaluate the effects of MediYoga, in respect of health-related quality of life, blood pressure, heart rate, as well as N-terminal pro b-type natriuretic peptide, among patients with symptomatic paroxysmal atrial fibrillation, compared with standard therapy or relaxation.
Methods:
Patients with symptomatic paroxysmal atrial fibrillation, n=132, were stratified for gender and randomised to MediYoga, a relaxation group or a control group, 44 patients per group with a 12-week follow-up. Health-related quality of life, blood pressure, heart rate and N-terminal pro b-type natriuretic peptide were assessed.
Results:
After 12 weeks, there were no differences in health-related quality of life between the groups. There were improvements in Short-Form Health Survey bodily pain, general health, social function, mental health and mental component summary scores within the MediYoga group (p=0.014, p=0.037, p=0.029, p=0.030, p=0.019, respectively). No change was seen in the relaxation and control groups. Systolic blood pressure decreased in the MediYoga group (134±18 to 127±13) compared with the control group (126±17 to 127±15, p=0.041); no difference compared with the relaxation group (131±17 to 125±12). Diastolic blood pressure decreased in the MediYoga group (79±9 to 74 ±9) compared with the control group (76±9 to 79±8, p=0.005); no difference compared with the relaxation group (76±9 to 77±8). There were no differences in heart rate and N-terminal pro b-type natriuretic peptide between the groups after 12 weeks.
Conclusions:
MediYoga improves health-related quality of life and decreases blood pressure in patients with paroxysmal atrial fibrillation. MediYoga may be used as a part of a self-management programme among patients with paroxysmal atrial fibrillation.
Wahlström, M., Rosenqvist, M., Medin, J., Walfridsson, U., & Rydell-Karlsson, M. (2019). MediYoga as a part of a self-management programme among patients with paroxysmal atrial fibrillation - a randomised study. European Journal of Cardiovascular Nursing. Epub ahead of print. https://doi.org/10.1177/1474515119871796